19-7690235-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001220500.2(FCER2):c.652G>A(p.Gly218Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000384 in 1,613,902 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001220500.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCER2 | NM_001220500.2 | c.652G>A | p.Gly218Ser | missense_variant | Exon 10 of 11 | ENST00000597921.6 | NP_001207429.1 | |
FCER2 | NM_002002.5 | c.652G>A | p.Gly218Ser | missense_variant | Exon 10 of 11 | NP_001993.2 | ||
FCER2 | NM_001207019.3 | c.649G>A | p.Gly217Ser | missense_variant | Exon 9 of 10 | NP_001193948.2 | ||
FCER2 | XM_005272462.5 | c.652G>A | p.Gly218Ser | missense_variant | Exon 10 of 11 | XP_005272519.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152168Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000716 AC: 18AN: 251364 AF XY: 0.0000589 show subpopulations
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461734Hom.: 0 Cov.: 33 AF XY: 0.0000138 AC XY: 10AN XY: 727180 show subpopulations
GnomAD4 genome AF: 0.000269 AC: 41AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.000283 AC XY: 21AN XY: 74328 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.652G>A (p.G218S) alteration is located in exon 10 (coding exon 9) of the FCER2 gene. This alteration results from a G to A substitution at nucleotide position 652, causing the glycine (G) at amino acid position 218 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at